Clinical Trial Update: Characterization of Myeloproliferative Neoplasia With a Mutated IDH, SRSF2 or SF3B1 Allele (CARPEDIEM)

View source ↗

Summary

This clinical trial update describes the CARPEDIEM study characterizing myeloproliferative neoplasms with mutated IDH, SRSF2, or SF3B1. The trial (NCT06481345) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Snippet

Sponsor: University Hospital, Brest | Conditions: Myeloproliferative Disorders | Status: ACTIVE_NOT_RECRUITING